`
`Elaine Herrmann Blais
`+1 617 570 1205
`eblais@goodwinlaw.com
`
`
`
`
`Goodwin Procter LLP
`100 Northern Avenue
`Boston, MA 02210
`
`goodwinlaw.com
`+1 617 570 1000
`
`
`August 23, 2021
`
`VIA ECF
`
`The Honorable Allison D. Burroughs
`United States District Court Judge
`John Joseph Moakley U.S. Courthouse
`1 Courthouse Way
`Boston, MA 02210
`
`
`Re:
`
`Teva Pharmaceuticals Int’l GmbH v. Eli Lilly & Co., No. 1:18-cv-12029-ADB
`
`Dear Judge Burroughs:
`
`We write on behalf of Plaintiffs Teva Pharmaceuticals International GmbH and Teva Pharmaceuticals
`USA, Inc. (collectively “Teva”) regarding the two related Orders issued by the Court on August 9, 2021
`(ECF Nos. 137, 138). Per the Court’s instructions, counsel for Teva has conferred with counsel for
`Defendant Eli Lilly and Company (“Lilly”), and the parties are in agreement that the Court’s sealed
`discovery Order (ECF No. 137) may be placed on the public docket without redaction.
`
`Respectfully Submitted,
`
`/s/ Elaine Herrmann Blais
`
`Elaine Herrmann Blais
`
`Counsel of Record (via ECF)
`
`cc:
`
`
`